SODIUM PUMP INHIBITORS IN BLOOD PRESSURE REGULATION
SODIUM PUMP INHIBITORS IN BLOOD PRESSURE REGULATION
批准号:
2565729
负责人:
A Y BAGROV
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
抑制内源性洋地黄样因子(EDLF)的浓度
高血压病患者和实验室的钠泵活性升高
动物,但它们的化学结构,这些海拔的原因,
而它们在高血压发生发展中的作用还有待阐明。
EDLF包括一种哇巴因类化合物(OLC),它主要来自肾上腺
起源,以及最近发现的一种蟾酥二烯内酯(即
MarinoBufagenin-like化合物或MBG),从它第一次出现以来就被称为
从蟾酥毒液中分离出来。我们实验室的研究表明,MBG
是一种作用更快、效力更强的大鼠主动脉收缩肌
OLC,在(A)期间刺激MBG的血浆浓度
犬的血浆扩张量,(B)条件呼吸
抑制,增加微型猪的二氧化碳分压,和(C)间隔
人类自愿的低通气量。在本年度内,
给予促肾上腺皮质激素(刺激
肾上腺皮质活动)七天后发现增加
MBG在血浆中的浓度及抑制血管内钠泵活性
大鼠的平滑肌肉。本研究表明,Na,K-ATPase的变化
血管平滑肌的活动不一定能从
红细胞Na,K-ATPase活性的变化。此外,MBG
研究发现,给药对α-1有更大的抑制作用
在血管平滑肌中占主导地位的Na,K-ATPase亚型,
与哇巴因相比,哇巴因有更强的抑制作用
对神经中占优势的Na,K-ATPaseα-3亚型的影响
组织细胞增加基因表达的能力
Na,K-ATPase对钠泵抑制作用的补偿
抑制剂以及对血管张力的影响仍有待阐明
MBG组持续升高的血压。
英文摘要
Concentrations of endogenous digitalis-like factors (EDLF) that inhibit
Na pump activity are elevated in hypertensive humans and laboratory
animals, but their chemical structures, the causes of these elevations,
and their role in the development of hypertension remain to be clarified.
EDLF include a ouabain-like compound (OLC) that is primarily of adrenal
origin, and a more recently discovered bufodienolide (i.e. a
marinobufagenin-like compound or MBG), so-called since it was first
isolated in toad venom. Studies in our laboratory have shown that MBG
is a more rapidly acting and more potent constrictor of rat aorta than
OLC, that plasma concentrations of MBG are stimulated during (a)
expansion on plasma volume of dogs, (b) conditioned respiratory
suppression that increases pCO2 in micropigs, and (c) intervals of
voluntary hypoventilation by humans. During the current year,
administration of adrenocorticotrophic hormone (which stimulates
adrenocortical activity) for seven days was found to increase
concentrations of MBG in plasma and inhibit Na pump activity in vascular
smooth muscle of rats. This study showed that changes in Na,K-ATPase
activity in vascular smooth muscle cannot necessarily be inferred from
changes in erythrocyte Na,K-ATPase activity. In addition, MBG
administration was found to have a greater inhibitory effect on alpha-1
isoforms of Na,K-ATPase, which predominate in vascular smooth muscle,
than administration of ouabain, while ouabain had a greater inhibitory
effect on alpha-3 isoforms of Na,K-ATPase, which predominate in neural
tissues The ability of cells to increase genetic expression of
Na,K-ATPase to compensate for inhibitory effects of sodium pump
inhibitors remains to be clarified, as do the effects on vascular tone
and blood pressure of sustained elevations in MBG.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SODIUM PUMP INHIBITORS IN CARDIOVASCULAR CONTROL
-
批准号:5200324
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:A Y BAGROV
-
依托单位:
SODIUM PUMP INHIBITORS IN CARDIOVASCULAR CONTROL
-
批准号:3745520
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:A Y BAGROV
-
依托单位:
SODIUM PUMP INHIBITORS IN CARDIOVASCULAR CONTROL
-
批准号:3767846
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:A Y BAGROV
-
依托单位:
海外基金